HealthTree Logo
search more_vert
close
person Sign In / Create Account

Loretta Nastoupil, MD

DLBCL Specialist

11 years treating Diffuse Large B Cell Lymphoma

Clinical Expertise

  • Diffuse Large B Cell Lymphoma
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma

About

 

The focus of my research has been on examining disparities in lymphoma survival to identify opportunities to design and implement rational clinical trials aimed at improving outcomes for high-risk patients. I have completed analyses using large databases in follicular lymphoma and diffuse large B-cell lymphoma (DLBCL) identifying characteristics that predict for inferior outcomes. My early efforts in this arena identified disparities in the use of potentially-curative, chemo-immunotherapy in the treatment of DLBCL patients. This study demonstrated that race and insurance status were associated with significant differences in the administration of chemo-immunotherapy among US patients with DLBCL.

Location

MD Anderson Cancer Center: 1515 Holcombe Blvd, Houston, TX 77030, USA

Get the latest thought leadership on Diffuse Large B Cell Lymphoma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Diffuse Large B Cell Lymphoma Newsletter" for Diffuse Large B Cell Lymphoma news, life with Diffuse Large B Cell Lymphoma stories, Diffuse Large B Cell Lymphoma clinical trials, Diffuse Large B Cell Lymphoma 101 articles and events with Diffuse Large B Cell Lymphoma experts.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram youtube